slotkoers
Korea S.E.
00:00:00 19-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
18.380
KRW
|
-0,97%
|
|
-4,27%
|
-22,28%
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
242.129
|
529.520
|
233.403
|
257.943
|
Bedrijfswaarde
1 |
237.216
|
520.707
|
224.952
|
244.495
|
K/w-verhouding
|
68,4
x
|
83,9
x
|
-209
x
|
3.079
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
3,39
x
|
6,65
x
|
2,88
x
|
3,1
x
|
Bedrijfswaarde/omzet
|
3,32
x
|
6,54
x
|
2,78
x
|
2,94
x
|
Bedrijfswaarde/EBITDA
|
34,8
x
|
70,4
x
|
26,3
x
|
28,3
x
|
Bedrijfswaarde/FCF
|
-50,8
x
|
519
x
|
161
x
|
-144
x
|
FCF Yield
|
-1,97%
|
0,19%
|
0,62%
|
-0,69%
|
Price to Book
|
5,21
x
|
9,21
x
|
3,9
x
|
3,76
x
|
Aantal aandelen (in duizenden)
|
10.907
|
10.907
|
10.907
|
10.907
|
Referentieprijs
2 |
22.200
|
48.550
|
21.400
|
23.650
|
Datum van publicatie
|
01-03-21
|
01-03-22
|
01-03-23
|
29-02-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
60.484
|
66.136
|
71.510
|
79.577
|
81.029
|
83.240
|
EBITDA
1 |
6.536
|
8.860
|
6.824
|
7.391
|
8.567
|
8.653
|
Bedrijfsresultaat (EBIT)
1 |
5.684
|
7.215
|
4.604
|
5.014
|
6.187
|
5.840
|
Operationele Marge
|
9,4%
|
10,91%
|
6,44%
|
6,3%
|
7,64%
|
7,02%
|
Resultaat voor belastingen (EBT)
1 |
4.781
|
6.958
|
3.768
|
5.208
|
-1.780
|
2.014
|
Nettowinst (verlies)
1 |
3.828
|
5.528
|
3.159
|
6.368
|
-1.119
|
83,76
|
Nettomarge
|
6,33%
|
8,36%
|
4,42%
|
8%
|
-1,38%
|
0,1%
|
WPA
2 |
444,0
|
629,0
|
324,3
|
579,0
|
-102,6
|
7,680
|
Free Cash Flow
1 |
3.516
|
7.221
|
-4.674
|
1.004
|
1.395
|
-1.693
|
FCF-marge
|
5,81%
|
10,92%
|
-6,54%
|
1,26%
|
1,72%
|
-2,03%
|
Kasstroomconversie (ebitda)
|
53,8%
|
81,5%
|
-
|
13,58%
|
16,29%
|
-
|
Kasstroomconversie (nettowinst)
|
91,85%
|
130,63%
|
-
|
15,76%
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
01-03-19
|
29-02-20
|
01-03-21
|
01-03-22
|
01-03-23
|
29-02-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
11.263
|
6.616
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
-
|
-
|
4.913
|
8.813
|
8.451
|
13.449
|
Hefboom (schuld/ebitda)
|
1,723
x
|
0,7467
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
3.516
|
7.221
|
-4.674
|
1.004
|
1.395
|
-1.693
|
ROE (netto-inkomsten/eigen vermogen)
|
19,1%
|
22,6%
|
8,64%
|
12,3%
|
-1,91%
|
0,13%
|
ROA (netto-inkomsten/totale activa)
|
6,15%
|
6,99%
|
3,89%
|
2,97%
|
2,97%
|
2,89%
|
Totale activa
1 |
62.216
|
79.048
|
81.288
|
214.112
|
-37.672
|
2.894
|
Nettoactief per aandeel
2 |
2.580
|
3.027
|
4.264
|
5.269
|
5.484
|
6.288
|
Cashflow per aandeel
2 |
835,0
|
1.188
|
1.546
|
5.184
|
769,0
|
3.798
|
Capex
1 |
1.734
|
1.348
|
1.974
|
2.552
|
2.465
|
1.531
|
Capex/omzet
|
2,87%
|
2,04%
|
2,76%
|
3,21%
|
3,04%
|
1,84%
|
Datum van publicatie
|
01-03-19
|
29-02-20
|
01-03-21
|
01-03-22
|
01-03-23
|
29-02-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -22,28% | 145 mln. | | +52,93% | 803 mld. | | +41,25% | 631 mld. | | -7,08% | 351 mld. | | +17,40% | 324 mld. | | +10,58% | 303 mld. | | +16,72% | 243 mld. | | +2,17% | 228 mld. | | +10,27% | 217 mld. | | +6,24% | 164 mld. |
Farmaceutische producten - Andere
|